Outcomes of electroconvulsive therapy in patients with depressive symptoms with versus without comorbid personality disorders/traits: A systematic review and meta-analysis

被引:5
|
作者
Ferrea, Stefano [1 ]
Petrides, Georgios [2 ,3 ,4 ]
Ehrt-Schafer, Yamina [1 ]
Angst, Jules [1 ]
Seifritz, Erich [1 ]
Olbrich, Sebastian [1 ]
Schoretsanitis, Georgios [1 ,2 ,3 ,5 ]
机构
[1] Univ Zurich, Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland
[2] Northwell Hlth, Psychiat Res, Zucker Hillside Hosp, Glen Oaks, NY USA
[3] Hofstra Northwell Sch Med, Hempstead, NY USA
[4] Feinstein Inst Med Res, Manhasset, NY USA
[5] Zucker Hillside Hosp, Behav Hlth Pavil, 7559 263rd St, Glen Oaks, NY 11004 USA
关键词
ECT; electroconvulsive therapy; major depressive disorders; mood disorders; personality disorders; personality traits; POSTTRAUMATIC-STRESS-DISORDER; MAJOR DEPRESSION; ELECTRODE PLACEMENT; ECT; SUICIDE; EFFICACY; CLUSTER; MEMORY; RISK;
D O I
10.1111/acps.13631
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Aims: To assess electroconvulsive therapy (ECT) outcomes in patients affected by depressive symptoms with versus without additional comorbid personality disorders/traits.Methods: We identified observational studies investigating ECT clinical outcomes in patients affected by depressive symptoms with versus without comorbid personality disorders/traits in Embase/Medline in 11/2022. Our protocol was registered with PROSPERO (CRD42023390833). Study quality was evaluated using the Newcastle-Ottawa-Scale. Our primary outcomes were ECT response and remission rates. Meta-regression analyses included effects of in/outpatient percentages, age, number of ECT sessions, and electrode placement; subgroup analyses included the assessment methods for personality disorders/traits. We performed sensitivity analyses after excluding poor-quality studies.Results: A total of 20 studies (n = 11,390) were included in our analysis. Patients with comorbid personality disorders/traits had lower remission rates (OR = 0.42, 95% CI = 0.31, 0.58, p < 0.001) with substantial heterogeneity (I-2 = 93.0%) as well as lower response rates (OR = 0.35, 95% CI = 0.24, 0.51, n = 5129, p < 0.001) with substantial heterogeneity (I-2 = 93.0%) compared with patients without comorbid personality disorders/traits. Relapse rates were higher in patients with versus without comorbid personality disorders/traits (OR = 3.23, 95% CI = 1.40, 7.45, k = 4, n = 239, p = 0.006) with moderate heterogeneity (I-2 = 75.0%) and post-ECT memory impairment was more frequent in patients with versus without comorbid personality disorders/traits (OR = 1.41, 95% CI = 1.36, 1.46, k = 4, n = 471, p < 0.001) with minimal heterogeneity (I-2 = 0.0%). Dropout rates were higher in patients with versus without comorbid personality disorders/traits (OR = 1.58, 95% CI = 1.13, 2.21, k = 3, n = 6145, p = 0.008).Conclusions: Patients with comorbid personality disorders/traits treated with ECT are reported to have lower response and remission rates and higher rates of side effects and relapse rates compared with patients without personality disorders/traits.
引用
收藏
页码:18 / 32
页数:15
相关论文
共 50 条
  • [41] Effectiveness of family-based therapy for depressive symptoms in children and adolescents: A systematic review and meta-analysis
    van Aswegen, Tanya
    Samartzi, Eleonora
    Morris, Linzette
    van Der Spek, Nadia
    de Vries, Ralph
    Seedat, Soraya
    van Straten, Annemieke
    INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2023, 58 (06) : 499 - 511
  • [42] Evaluation of Etomidate for Seizure Duration in Electroconvulsive Therapy A Systematic Review and Meta-analysis
    Singh, Preet Mohinder
    Arora, Shubhangi
    Borle, Anuradha
    Varma, Prerna
    Trikha, Anjan
    Goudra, Basavana Gouda
    JOURNAL OF ECT, 2015, 31 (04) : 213 - 225
  • [43] Influence of an adjuvant antidepressant on the efficacy of electroconvulsive therapy: A systematic review and meta-analysis
    Pluijms, Esther M.
    Kamperman, Astrid M.
    Hoogendijk, Witte J. G.
    Birkenhager, Tom K.
    van den Broek, Walter W.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2021, 55 (04): : 366 - 380
  • [44] Back pain and depressive symptoms: A systematic review and meta-analysis
    Amiri, Sohrab
    Behnezhad, Sepideh
    Azad, Esfandiar
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2020,
  • [45] Increased BDNF levels after electroconvulsive therapy in patients with major depressive disorder: A meta-analysis study
    Rocha, Renan Boeira
    Dondossola, Eduardo Ronconi
    Grande, Antonio Jose
    Colonetti, Tamy
    Ceretta, Luciane Bisognin
    Passos, Ives C.
    Quevedo, Joao
    da Rosa, Maria Ines
    JOURNAL OF PSYCHIATRIC RESEARCH, 2016, 83 : 47 - 53
  • [46] Borderline Personality Disorder and Outcome of Electroconvulsive Therapy in Patients With Depression A Systematic Review
    Nicolini, Alain P.
    Sienaert, Pascal
    JOURNAL OF ECT, 2023, 39 (02) : 74 - 80
  • [47] Cortisol as a predictor of psychological therapy response in depressive disorders: systematic review and meta-analysis
    Fischer, Susanne
    Strawbridge, Rebecca
    Vives, Andres Herane
    Cleare, Anthony J.
    BRITISH JOURNAL OF PSYCHIATRY, 2017, 210 (02) : 105 - 109
  • [48] Systematic review and meta-analysis of the prevalence of depressive symptoms, dysthymia and major depressive disorders among homeless people
    Ayano, Getinet
    Belete, Asmare
    Duko, Bereket
    Tsegay, Light
    Dachew, Berihun Assefa
    BMJ OPEN, 2021, 11 (02):
  • [49] Do statins have an effect on depressive symptoms? A systematic review and meta-analysis
    Yatham, Megha Sai
    Yatham, Kavya Sai
    Ravindran, Arun, V
    Sullivan, Frank
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 257 : 55 - 63
  • [50] Ketamine administration in depressive disorders: a systematic review and meta-analysis
    Guillaume Fond
    Anderson Loundou
    Corentin Rabu
    Alexandra Macgregor
    Christophe Lançon
    Marie Brittner
    Jean-Arthur Micoulaud-Franchi
    Raphaelle Richieri
    Philippe Courtet
    Mocrane Abbar
    Matthieu Roger
    Marion Leboyer
    Laurent Boyer
    Psychopharmacology, 2014, 231 : 3663 - 3676